MX2019007547A - Composicion hemostatica que comprende un intercambiador de aniones y una sal de calcio. - Google Patents
Composicion hemostatica que comprende un intercambiador de aniones y una sal de calcio.Info
- Publication number
- MX2019007547A MX2019007547A MX2019007547A MX2019007547A MX2019007547A MX 2019007547 A MX2019007547 A MX 2019007547A MX 2019007547 A MX2019007547 A MX 2019007547A MX 2019007547 A MX2019007547 A MX 2019007547A MX 2019007547 A MX2019007547 A MX 2019007547A
- Authority
- MX
- Mexico
- Prior art keywords
- calcium salt
- anion exchanger
- hemostatic composition
- hemostatic
- composition
- Prior art date
Links
- 150000001450 anions Chemical class 0.000 title abstract 2
- 159000000007 calcium salts Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002439 hemostatic effect Effects 0.000 title 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000023597 hemostasis Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/208—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proporcionan composiciones que comprenden un intercambiador de aniones y una sal de calcio para usar como un medicamento para inducir la hemostasia en un sitio de sangrado; y métodos de preparación de estas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662437840P | 2016-12-22 | 2016-12-22 | |
IL249725A IL249725A0 (en) | 2016-12-22 | 2016-12-22 | A hemostatic preparation containing an anion exchanger and a calcium salt |
PCT/IL2017/000009 WO2018116287A1 (en) | 2016-12-22 | 2017-12-13 | Hemostatic composition comprising an anion exchanger and a calcium salt |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019007547A true MX2019007547A (es) | 2020-02-07 |
Family
ID=62624836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019007547A MX2019007547A (es) | 2016-12-22 | 2017-12-13 | Composicion hemostatica que comprende un intercambiador de aniones y una sal de calcio. |
Country Status (5)
Country | Link |
---|---|
US (1) | US11857564B2 (es) |
IL (1) | IL249725A0 (es) |
MX (1) | MX2019007547A (es) |
RU (1) | RU2756446C2 (es) |
WO (1) | WO2018116287A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL247786B (en) * | 2016-09-12 | 2019-08-29 | Plotkin Alexander | Covers the wound with a hemostatic action and method and creates it |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923645A (en) | 1987-11-16 | 1990-05-08 | Damon Biotech, Inc. | Sustained release of encapsulated molecules |
WO1993005822A1 (en) | 1991-09-27 | 1993-04-01 | Octapharma Ag | Tissue glue prepared by using cryoprecipitate |
US5502042A (en) * | 1994-07-22 | 1996-03-26 | United States Surgical Corporation | Methods and compositions for treating wounds |
US6056970A (en) * | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
WO2005072700A2 (en) | 2004-01-30 | 2005-08-11 | Ferrosan A/S | Haemostatic sprays and compositions |
US20080145455A1 (en) | 2006-12-13 | 2008-06-19 | Bedard Robert L | Combination of Inorganic Hemostatic Agents with Other Hemostatic Agents |
US8932560B2 (en) | 2007-09-04 | 2015-01-13 | University of Maryland, College Parke | Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells |
US8110208B1 (en) * | 2009-03-30 | 2012-02-07 | Biolife, L.L.C. | Hemostatic compositions for arresting blood flow from an open wound or surgical site |
EP2575906B1 (en) | 2010-05-24 | 2014-12-10 | University of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
US10022410B2 (en) | 2010-12-22 | 2018-07-17 | Ethicon, Inc. | Hemostatic preparation containing an extract of golden moss |
CN109602944A (zh) * | 2011-11-13 | 2019-04-12 | 克里斯龙公司 | 原位可交联的聚合物组合物及其方法 |
-
2016
- 2016-12-22 IL IL249725A patent/IL249725A0/en unknown
-
2017
- 2017-12-13 MX MX2019007547A patent/MX2019007547A/es unknown
- 2017-12-13 WO PCT/IL2017/000009 patent/WO2018116287A1/en unknown
- 2017-12-13 US US15/840,329 patent/US11857564B2/en active Active
- 2017-12-13 RU RU2019122640A patent/RU2756446C2/ru active
Also Published As
Publication number | Publication date |
---|---|
WO2018116287A1 (en) | 2018-06-28 |
RU2019122640A3 (es) | 2021-02-26 |
RU2019122640A (ru) | 2021-01-22 |
IL249725A0 (en) | 2017-03-30 |
US20180177818A1 (en) | 2018-06-28 |
US11857564B2 (en) | 2024-01-02 |
RU2756446C2 (ru) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
BR112017022604A2 (pt) | composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação | |
AU2015247815A8 (en) | Ion channel activators and methods of use | |
BR112017023161A2 (pt) | composições de ácido obeticólico e métodos de uso | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
BR112016015706A8 (pt) | composto, uso do mesmo e composição farmacêutica | |
PH12018500446A1 (en) | Pyridinone dicarboxamide for use as bromodomain inhibitors | |
BR112014021531A8 (pt) | composto, composição farmacêutica e usos dos mesmos | |
PH12016501807A1 (en) | Novel compounds | |
PH12017500533A1 (en) | 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
EP3528857A4 (en) | COMPOSITIONS FOR HAMOSTASIS, REPAIR AND TISSUE RECONSTRUCTION | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
BR112017008178A2 (pt) | ativador do canal de kcnq2-5 | |
BR112018006545A2 (pt) | ?composto, composição farmacêutica, combinação, uso de um composto, e, método para tratamento de uma doença ou condição? | |
MY177933A (en) | Herbicidal composition comprising quizalofop-p | |
PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
CO2019006822A2 (es) | Composición hemostática que comprende un intercambiador de aniones y una sal de calcio | |
PH12018500433A1 (en) | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | |
MX2019007547A (es) | Composicion hemostatica que comprende un intercambiador de aniones y una sal de calcio. | |
BR112017009848A2 (pt) | combinação, composição farmacêutica, kit, e, método para preparar uma composição farmacêutica. | |
MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
WO2016073493A3 (en) | Antifibrinolytic compounds |